Table 1.
Demographic and clinical characteristics of SSc patients.
| Characteristics | Scleroderma patients (number 81) |
|---|---|
| Age (years) (mean ± standard deviation) | 63.9 ± 13.1 |
| Sex (F/M) (number) | 74/7 |
| Disease duration (years) (mean ± standard deviation) | 12.4 ± 8.9 |
| Clinical form (limited/diffuse) (number) | 59/22 |
| Antinucleus autoantibody positivity (number) | 74 |
| Anticentromere autoantibody positivity (number) | 41 |
| Anti-SCL70 autoantibody positivity (number) | 19 |
| Erythrocyte sedimentation ratio, 1st hour mm (median, range) | 15, 2.0–84 |
| C-reactive protein, mg/L (median, range) | 2.1, 0–24 |
| Serum creatinine, mg/dL (median, range) | 0.7, 0.49–2.22 |
| Digital ulcers (number) | 18 |
| Calcinosis (number) | 14 |
| Pulmonary artery hypertension screened through 2D echocardiography (number) | 19 |
| Lung interstitial disease (number) | 35 |
| Diffusing capacity or transfer factor of the lung for carbon monoxide per unit alveolar volume (%) (mean ± standard deviation) | 83.3 ± 15.2 |
| Vital capacity (%) (mean ± standard deviation) | 100.3 ± 17.4 |
| Medsger's scale score (mean ± standard deviation) | 4.3 ± 2.3 |
| Modified Rodnan skin score (median, range) | 4.5, 0–30 |
| Osteoporosis (number) | 32 |